Abundance International (SGX:570) established a medical and technological research and development company in China, named Abundance Biomedical (Shanghai), according to a Tuesday filing with the Singapore Exchange.
The company has a registered capital of 3.5 million yuan and is part of the waste management company's strategy of commercialization and production of CypH-11.